Compare CETX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CETX | NUWE |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 2.9M |
| IPO Year | 1998 | N/A |
| Metric | CETX | NUWE |
|---|---|---|
| Price | $2.18 | $2.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.5M | 49.4K |
| Earning Date | 12-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,095,551.00 | $8,167,999.00 |
| Revenue This Year | $19.77 | N/A |
| Revenue Next Year | $15.00 | $10.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.50 | N/A |
| 52 Week Low | $2.16 | $2.02 |
| 52 Week High | $55.50 | $70.14 |
| Indicator | CETX | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 41.63 | 43.03 |
| Support Level | $2.16 | $2.10 |
| Resistance Level | $2.47 | $2.35 |
| Average True Range (ATR) | 0.98 | 0.19 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 0.66 | 15.71 |
Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.